Singh is a professor of oncologic sciences and head of the Health Disparities in Cancer Research Program at USA Health Mitchell Cancer Institute. He joined MCI in 2009.
“Dr. Singh is an outstanding scientist and a leader at MCI,” said MCI Interim Director Dr. Rodney P. Rocconi. “I’m so pleased that his research is being recognized at this level.”
Singh’s research focuses on the molecular mechanisms involved in cancer progression and chemoresistance, and the development of novel mechanism-based approaches for cancer therapy and prevention.
Singh received his Ph.D. in life science from Devi Ahilya University in India and completed postdoctoral training in cancer biology at the University of Nebraska Medical Center/Eppley Cancer Institute in Omaha, Nebraska. He has received numerous honors and awards and is a co-inventor on five issued U.S. patents of which three were granted for his discoveries relating to prostate and pancreatic cancer. He has been awarded research grants from all major federal funding agencies including the National Institutes of Health, the National Science Foundation and the U.S. Department of Defense.
Singh also is a recipient of the University of South Alabama 2016 Russell and Robin Lea National Alumni Excellence in Faculty Innovation Award and the 2016 Mayer Mitchell Award for Excellence in Cancer Research.
The Society of American Asian Scientists in Cancer Research is a nonprofit organization of more than 5,000 scientists from Asia who are working in the U.S. and Canada in the field of cancer research.
